AU Patent

AU2021345429A1 — Aqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol

Assigned to Antares Pharma Inc · Expires 2023-05-04 · 3y expired

What this patent protects

Aqueous hydrocortisone sodium phosphate and monothioglycerol formulations are disclosed.

USPTO Abstract

Aqueous hydrocortisone sodium phosphate and monothioglycerol formulations are disclosed.

Drugs covered by this patent

testosterone-enanthate (TESTOSTERONE ENANTHATE)

Patent Metadata

Patent number: AU2021345429A1
Jurisdiction: AU
Classification: —
Expires: 2023-05-04
Drug substance claim: No
Drug product claim: No
Assignee: Antares Pharma Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.